Earnings History for Simcere Pharmaceutical Group. (SCR)
|
Expand Research on SCR
| Next EPS Date | 8/9/13 *Est. | EPS Growth Rate | +600.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -10.0% | Revenue Growth Rate | +583.1% *Last Qtr. |
| Average % Move 1-Wk after EPS | +2.3% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/9/13  |
 |
Q113 | RMB0.56 | N/A | N/A | RMB528.73M | RMB487.61M | N/A / N/A | N/A | +2% | Details |
| 3/7/13 |
|
Q412 | -$0.06 | $0.00 | -$0.06 | $86.7M | $88.06M | N/A / N/A | N/A | +15.6% | Details |
| 11/15/12 |
|
Q312 | $0.07 | $0.07 | $0.00 | $83.8M | $85.72M | N/A / N/A | N/A | +19.5% | Details |
| 8/10/12 |
|
Q212 | $0.08 | $0.10 | -$0.02 | $83.2M | $86.83M | N/A / N/A | N/A | +16.1% | Details |
| 5/9/12 |
|
Q112 | $0.08 | $0.10 | -$0.02 | $77.4M | $84.31M | N/A / N/A | N/A | +3.6% | Details |
| 3/7/12 |
|
Q411 | $0.12 | $0.10 | +$0.02 | $81.2M | $86.35M | N/A / N/A | N/A | +12.6% | Details |
| 11/14/11 |
|
Q311 | $0.10 | $0.15 | -$0.05 | $78.5M | $94.66M | N/A / N/A | N/A | +6.9% | Details |
| 8/9/11 |
|
Q211 | $0.21 | $0.13 | +$0.08 | $84.4M | $90.61M | N/A / N/A | N/A | -1.9% | Details |
